Cannabis Science: Helping Fibro Sufferers

The company Cannabis Science, which produces cannabis-based medications, has announced that they have developed two different medications which offer hope for the treatment of pain in patients suffering from fibromyalgia and diabetic neuropathy. The products are cannabis-based transdermal patches which deliver the medication directly through the user’s skin.

Transdermal medication has the advantage of being able to target a specific area of the body, as opposed to the systemic approach of oral and intravenous application. Because of this and the slow release of the medication which allows a higher level of control over dosage, transdermal applications hold great promise for treating nerve pain in certain patients.

The patches produced by Cannabis Science slowly release medication which is either slowly absorbed through a porous membrane or layers of medication-impregnated material which melt in response to body heat over time.

Cannabis-based medications are becoming widely accepted, although the plant itself has been used medicinally for millennia. There is a growing body of peer reviewed studies which provide thorough documentation of the ways that cannabinoids can modulate human biochemistry for therapeutic ends.

The company’s transdermal patches contain the active ingredient CBD, a cannabinoid contained in marijuana – it’s the second major cannabinoid contained in the plant after THC. CBD does not produce the intoxicating effects characteristic of THC, but acts as a potent pain reliever which acts directly on the patient’s central nervous system.

CBD offers pain relieving and anti-inflammatory properties without being a psychoactive compound like THC. However, it has been shown in studies to be highly effective in treating pain, especially pain linked to inflammation – in fact, some research has suggested that CBD may be more effective in treating inflammatory pain than traditional medications.

Cannabis Science CEO Raymond C. Dabney said in a press release announcing the new medications, “As more states nationwide [in the U.S.] legislate for the legalization of cannabis and cannabis-derived medications, we here at Cannabis Science are focused on developing pharmaceutical formulations and applications to supply the huge growing demand expected over the coming few years.”

The product may be able to provide significant relief to patients living with fibromyalgia, a chronic condition which can cause severe pain and sensitivity to pressure which affects an estimated 2% -8% of people.

Fibromyalgia and Fatigue The nation's leading expert on persistent fatigue as well as fibromyalgia supplies a functional and concise overview of how to bring back health, wellness and also energy in your life. Countless Americans have looked to DOCTOR Jacob Teitelbaum's landmark Coming from Fatigued to Fantastic, the enduring very popular book on combating disabling fatigue and also fibromyalgia.

Right now, The Fatigue and Fibromyalgia Answer provides the best cutting-edge research and clinical details, supplying the most up to date breakthroughs in addressing fatigue syndrome...


Comments are closed.

Copyright © The Fibromyalgia Wire